Compare KOD & ZENV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KOD | ZENV |
|---|---|---|
| Founded | 2009 | 2005 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 795.5M | 70.8M |
| IPO Year | 2018 | 2021 |
| Metric | KOD | ZENV |
|---|---|---|
| Price | $22.88 | $1.23 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $22.67 | N/A |
| AVG Volume (30 Days) | ★ 720.6K | 28.3K |
| Earning Date | 11-13-2025 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $201,426,369.00 |
| Revenue This Year | N/A | $12.75 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 24.80 |
| 52 Week Low | $1.92 | $1.02 |
| 52 Week High | $26.21 | $3.03 |
| Indicator | KOD | ZENV |
|---|---|---|
| Relative Strength Index (RSI) | 54.93 | 47.04 |
| Support Level | $21.24 | $1.16 |
| Resistance Level | $26.21 | $1.27 |
| Average True Range (ATR) | 1.67 | 0.06 |
| MACD | -0.16 | 0.01 |
| Stochastic Oscillator | 40.65 | 64.74 |
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
Zenvia Inc provides a platform that enables companies to create journeys for their end customers across a variety of channels. The company operates in two reportable segments namely CPaaS and SaaS. It has a geographic presence in Brazil, the USA, Argentina, Mexico, and Others. The company generates the majority of its revenue from Brazil.